BeyondSpring BYSI
NASDAQ BYSI
$0.73 +0.01 (+1.97%)
As of: Aug 21, 2026 · 10:53 AM EDT

BeyondSpring (BYSI) FCF Margin Growth (3y) (2024)

BeyondSpring (BYSI) FCF Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.40 Bn 131.55 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn -2,228.00
3 Argenx Se 65.20 Bn 60.02 Bn 1.37 Bn -
4 Moderna 60.40 Bn 55.26 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.36 Bn 28.05 Bn 992.69 Mn 4,612.00
7 BioNTech SE 28.74 Bn 10.34 Bn 668.28 Mn 1,850.00
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.17 Bn 26.33 Bn - -3,088.00
10 BeyondSpring 30.17 Mn 30.17 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -111,190.00